I’ve never seen such a streamlined process for literature search and review. CiteMed produced elegant reports that were easy to read despite their length and incredible detail”
A Targeted Approach to EU MDR
You already know that the Literature Search and Review is the cornerstone of your Clinical Evaluation Report.
If your team has been working on these for awhile, then you also know it can be the most labor intensive and time consuming part of the entire process.
The formatting alone can drain substantial hours of your writer’s time. Hours much better spent on the more product knowledge intensive parts of your submission.
The CiteMed team was formed to be able to deliver a high volume of beautifully written and formatted Literature Reviews on timelines that will enable you to meet your EU MDR goals.
We don’t outsource, all research is read and reviewed by internal qualified writers dedicated to your product lines.
We leverage a software platform that we built in-house to perfect the formatting of uniform and error free submissions.
Humans read and write, while we let the machines handle the arduous tasks of formatting and error handling. The result is consistency across all of your literature review submissions.
Notified Body Approved Approach
Our previously completed Literature Searches have been accepted across Europe without scrutiny in addition to several Asian markets like China and Malaysia.
Know Where to Start – Our approach can drive your whole regulatory review process.
Speed – Collaborative, rapid decision point schedules keep your project moving. You will have trouble keeping up
Accuracy – Internal systems validate research data
Fixed Pricing – Upfront costs established based on a proven and logistic model.
Human and Technology Driven – State of the Art Reports, Follow-Up Reporting Requirements and Research Management Software visually manages all projects and stages of completion.
We are committed to keeping our approach current with Industry standards and improving our tools to meet the strictest reviews of Notified Bodies.
Streamlined Process
We’ve taken a once cumbersome process of approval/revision and flattened it out to slash delivery time and avoid endless revisions for the new EU MDR standards.
Top Research
We search major safety databases and Published Journal databases for specific key words related to your product or concept product.
Proven Reg Staff
We have in-house MD writers that review all research for your submissions.
Post Market Surveillance
All projects are stored in our product Vault for ease of future compliance filings down the line. Adverse Event Databases can also be monitored for events specific to your product.
Latest Publications
Post-Brexit Medical Device Regulatory Compliance – UK MHRA Guidance
In accordance with the guidance posted by the UK Medicines and Healthcare products Regulatory Agency (MHRA), from 1 January 2021 the MHRA will undertake the responsibilities for the UK medical devices market, previously [...]
Your NB’s Clinical Evaluation Assessment Report
MDCG’s Guidance document, released in July 2020, introduces and details the key requirements and format of a Clinical Evaluation Assessment Report (CEAR) to be documented by Notified Bodies (NBs) as a part of its [...]
An Understanding of the Clinical Evaluation Process in China – Comparison with EU MDR
Medical device regulations in China are often likened to the European Union (EU)’s MDR, with a vital prerequisite of Clinical Evaluation Reports (CERs), as required by China’s National Medical Products Administration NMPA (formerly CFDA). [...]